As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...

Five deals that showcase the potential dealmakers see in the surgical equipment segment. Ampersand Capital, PAI Partners and ...

Our four modules (15 minutes a day) provide an introduction to the basics of clinical trial project management with skills, tools and local resources you can use immediately. Module 1: Project Manager ...

Linical, a leader in clinical research services, is proud to celebrate its 20th anniversary - a milestone that reflects two ...

An expert discusses how combining androgen receptor pathway inhibitors (ARPIs) with PARP inhibitors, particularly ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...

Novo Nordisk ( NVO 6.12%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...